![]() |
市場調查報告書
商品編碼
1433393
全球NGS樣品製備市場 2023-2030Global NGS Sample Preparation Market 2023-2030 |
預計在預測期內(2023-2030年),全球NGS樣品製備市場將以14.7%的CAGR顯著成長。市場的成長歸因於定序成本下降導致對基因組定序的高需求。不斷努力最大限度地降低測序總成本有助於 NGS 樣品製備市場的成長。簡化樣本庫製備方法有助於顯著降低成本。例如,2023年 11月,New England Biolabs(NEB)發布了 NEBNextUltraExpress DNA 和 RNA 樣品庫製備試劑盒,用於 Illumina 平台上的下一代定序。新試劑盒提供了更快、更簡單的工作流程來產生高品質的樣品庫,允許在一天或兩小時內完成 RNA 和 DNA 樣品庫的製備,並具有自動化友善的工作流程和最小化的耗材浪費。然而,低成本替代品的容易取得可能會限制市場的成長。
全球 NGS 樣品製備市場依產品類別、應用和最終用戶進行細分。根據產品類別,市場細分為試劑和消耗品以及工作站。根據應用,市場細分為診斷、藥物發現等。此外,根據最終用戶,市場細分為醫院和診所、學術和研究機構、製藥和生物技術公司等。診斷子類別預計將佔據產品類別領域的很大一部分市場佔有率。這是由於對基於NGS的臨床診斷的需求不斷成長以及包括癌症在內的遺傳疾病的盛行率不斷增加。
在這個產品類別中,工作站細分市場預計將在全球 NGS 樣品製備市場中佔據相當大的佔有率。該細分市場的成長歸因於實驗室自動化需求的增加。實驗室迅速採用自動化解決方案,以處理不斷增加的樣品量、提高效率並減少動手時間。 Fontus 工作站透過提供自動化液體處理解決方案來滿足需求。例如,2023年7月,Revvity 推出了Fontus 自動液體處理工作站,這是一款下一代液體處理程序,融合了公司先前平台的最先進技術,目的是提供更簡單、更快速的工作流程,為下一代定序(NGS)提供更好的結果和診斷研究應用。
全球NGS樣品製備市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區),以及世界其他地區(中東和非洲以及拉丁美洲)。其中,預計亞太地區在預測期內將呈現最快的CAGR。中國和印度等發展中國家擴大使用NGS技術,以及各個領域對基於NGS的研究的需求不斷增加,這是促進區域市場成長的關鍵因素。
北美在全球 NGS 樣品製備市場中佔有相當大的佔有率
Global NGS Sample Preparation Market Size, Share &Trends Analysis Report by Product Class(Reagent and Consumables, and Workstations), by Application (Diagnostics, Drug Discovery, and Others)and by End-User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others), Forecast Period (2023-2030)
The global NGS sample preparation market is anticipated to grow at a significant CAGR of 14.7% during the forecast period (2023-2030).The market's growth is attributed to the high demand for genome sequencing due to decreasing sequencing costs. Continuous efforts to minimize the overall cost of sequencing have aided in the growth of the NGS Sample Preparation Market. Streamlining library preparation methods helps to considerably reduce costs. For instance, in November 2023, New England Biolabs (NEB) released the NEBNextUltraExpress DNA and RNA Library Prep Kits for next generation sequencing on the Illumina platform. New kits offer a faster, easier workflow for generating high-quality libraries, allowing RNA and DNA library prep in a single day or two hours, with automation-friendly workflows and minimal consumable waste. However, the easy availability of low cost alternative may restrain the market growth.
The global NGS sample preparation market is segmented on the product class, application and end-user. Based on the product class, the market is sub-segmented into reagent and consumables, and workstations. Based on the application, the market is sub-segmented into diagnostics, drug discovery, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and others. The diagnostics subcategory is expected to capture a significant portion of the market share within the product class segment. This is attributed to the growing demand for NGS-based clinical diagnostics and the increasing prevalence of genetic diseases including cancer.
Among the product class, the workstations sub-segment is expected to hold a considerable share of the global NGS Sample Preparation market. The segmental growth is attributed to the increased demand for automation in laboratories. Laboratories are rapidly adopting automated solutions in order to handle the increasing volume of samples, improve efficiency, and reduce hands-on time. Fontus workstations satisfy the demand by providing automated liquid handling solutions. For instance, in July 2023, Revvity launched the Fontus Automated Liquid Handling Workstation, a next-generation liquid handler that incorporates the greatest technology from company's previous platforms and is designed to provide easier and faster workflows that provide better results for next generation sequencing(NGS) and diagnostic research applications.
The global NGS sample preparation market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The rising use of NGS technology in developing countries such as China and India, in addition to increasing demand for NGS-based research in a variety of fields are key factors contributing to the regional market growth.
The North America Holds Considerable Share in the Global NGS Sample Preparation Market
Among all regions, the North America holds considerable share in the global market. Regional growth is attributed to the sample standardization challenges. Sample variability due to varied origins is a challenges for standardization. It is essential to develop robust protocols that account for varied sample properties in order to achieve accurate pooling and subsequent read separation. According to the BMC Genomics, in August 2022,DNA and RNA sequencing is a widely used procedure for identifying diseases, understanding cell regulation, and understanding cell replication dynamics. Despite significant price reductions in the last decade, the final library sequencing only covers 20% of the total costs of a 10 million read sequencing project.
Automation could be an option for future cost reduction, but samples are not standardized due to their different origins. An approach to pool samples of different organisms and separate DNA/RNA reads bioinformatically after pooled sample preparation and sequencing could reduce total costs for DNA and RNA sequencing to 50%. This study investigates the limits of sample pooling for high-quality genomics and transcriptomics applications, considering error rates and evolutionary distances.
The major companies serving the NGS sample preparation market includes Bio-Rad Laboratories, Inc., Danaher Corp, DNASTAR, Huawei Technologies Co. Ltd, and Illumina, Inc. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, QIAGEN acquired of Verogen, strengthening leadership\ in Human ID / the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation. It offers DNA collection, preparation kits, genetic testing analysis, and workflow automation products for forensic science laboratories and criminal investigators globally.